This study is in progress, not accepting new patients
Nicotinamide as an Early Alzheimer's Disease Treatment
Summary
- Eligibility
- for people ages 50 years and up (full criteria)
- Location
- at Irvine, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Joshua Grill
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UC Irvine
- Joshua Grill
Professor, Psychiatry. Authored (or co-authored) 79 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, Irvine
- ID
- NCT03061474
- Phase
- Phase 2 Research Study
- Study Type
- Interventional
- Participants
- Expecting 48 study participants
- Last Updated